The Altium Capital was first founded by Jacob Gottlieb and Stuart Weisbrod, after the scandal that left Gottlieb’s former hedge fund company, Visium, down the tracks. Weisbrod and Gottlieb had been working together prior to starting this company when they worked at Merlin BioMed Group. Their investing firms typically centered around the health care industry, most notably, in the areas of biotechnology, pharmaceuticals, and healthcare service sectors. However, Weisbrod and Gottlieb and eventually closed down the Merlin BioMed Group in 207 after returning its investors’ funds. After this event, Weisbrod went on to create Iguana Healthcare Partners, while Gottlieb created the investment firm, Visium.
Under Gottlieb’s management, Visium went on to become a billion dollar investment firm after starting with an initial capital of $300 million. As the CEO of Visium, he was able to grow the company into $2.5 billion in 2008 and to almost $8 billion over the next few years. However, in 2016, Visium’s growth came to an end after a scandal involving three executives came into light. They were essentially being charged for insider trading and mismarking. Because of this, an investigation was launched by the SEC on the company. Gottlieb, however, was cleared of any charges and he began to return the funds made by investors until he closed down the company.
After this incident, Gottlieb and Weisbrod eventually came together to form the Altium Capital, another investment firm focused on the healthcare industry. Because of their healthcare background, Altium first invested in Oramed Pharmaceuticals Inc, with a 5.61% stake in the company. Essentially, Oramed had been focused on creating an oral insulin that could potentially replace injected insulin into the body. Because of the possibility of improving the healthcare industry, Altium Capital readily invested into this company in the hopes of someday revolutionizing healthcare practices worldwide.
Find out more about Jake Gottlieb Altium: https://www.linkedin.com/in/jacob-gottlieb/